The mRNA transcripts from a mutant β-globin gene derived from splicing at preferential cryptic sites  by Lossi, Anne-Marie & Bergé-Lefranc, Jean-Louis
Volume 256, number 1,2, 163-166 FEB 07697 October 1989 
The mRNA transcripts from a mutant /I-globin gene derived from 
splicing at preferential cryptic sites 
Anne-Marie Lossi and Jean-Louis Berg&Lefranc 
INSERM U38, FacultP de Mkdecine, 27 Boulevard Jean Moulin, 13385 Marseille Ckdex 5, France 
Received 26 July 1989 
We have analyzed mRNA transcripts from p-globin genes carrying a homozygous point mutation at the 5’ splicing site 
of the first intron, using a method allowing in vivo analysis of mRNA transcripts. As expected, this mutation decreases 
normal splicing of mRNA when cryptic splicing sites are utilized. We have observed that, in reticulocytes, most mature 
mRNA transcribed from /l-globin genes derives from specific sites of abnormal splicing. Our results differ from those 
previously obtained using mutant /I-globin genes introduced in cultured cells and indicate a preferential processing of 
the abnormal globin mRNA species in red cell precursors. 
Thalassemia, j3-; mRNA splicing 
1. INTRODUCTION ween red blood cell precursors and transformed 
cells, as previously suggested [4,5]. 
The human @-globin gene provides a good model 
for understanding the mechanism of mRNA 
transcription and processing. Several point muta- 
tions in &globin genes have been observed at the 
junction of exons and introns and particularly in 
the GT dinucleotide at the 5’ splicing site. Those 
mutations are responsible for ,&thalassemia 
(reviewed in [ 11). It is now well-established that the 
GT dinucleotide is necessary for correct splicing of 
mRNA precursors [2], 
The most commonly used procedure to in- 
vestigate the effect of mutation at the splicing sites 
has been the analysis of the expression of cloned 
mutant genes after introduction in cultured cells. 
This procedure has made it possible to show that 
mutation in the 5 ’ or 3 ’ splicing site consensus e- 
quences results in abnormal splicing due to the ac- 
tivation of cryptic splicing sites (reviewed in [3]). 
This approach, however, does not take into con- 
sideration differences in tissue-specific factors bet- 
In the present report, we studied the conse- 
quences of a point mutation observed on both 
alleles of a patient affected by fl-thalassemia. This 
mutation lies in the GT dinucleotide of the splice 
junction of the first intron (IVS 1) of the @-globin 
gene (IVS l-2 T - C). &Globin cDNAs were 
prepared from reticulocytes and further amplified 
by polymerase chain reaction (PCR) [6] in order to 
determine the in vivo effect of the mutation on 
splicing and maturation of mRNA occurring in the 
red cell precursors of the patient. 
2. MATERIALS AND METHODS 
2. I. Subject 
The patient was diagnosed, using conventional laboratory in- 
vestigation, as having,&thalassemia. He was affected by a mild 
form of ,&thalassemia, and was not regularly transfused. He 
had not been splenectomized. DNA analysis was performed. 
We determined that the molecular defect was a homozygous 
mutation (T-C) at position IVS 1-2. 
2.2. Oiigonucleotide used 
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CAC-3’) were synthesized on a Pharmacia gene assembler 
(Pharmacia LKB, Sweden). Palm 4 is complementary to the ,& 
globin mRNA sequence of the second exon of the fl-globin 
gene. The palm C sequence is localized in the first exon of the 
fl-globin gene. Detection of @-globin mRNA transcripts was 
performed with an oligonucleotide commonly used to detect a 
normal coding region of the @globin gene [8] that is located 
between the sites used for PCR amplification. 
2.3. Amplification and sequencing 
RNA of blood cells was prepared following lysis in 
guanidinium thiocyanate and cesium chloride purification [7]. 
cDNA was synthesized and further amplified according to the 
method described in [9] with the following modifications: 
cDNA was synthesized from 0.5 pg RNA using palm 4 as 3’ 
primers. After addition of 50 pmol each of palm 4 and palm C, 
PCR amplification was performed. Amplified products were 
separated on 5% acrylamide gels and excised from the gel. Gel 
pieces were scratched into 0.2-0.5 ml of 10 mM Tris/l mM 
EDTA. After heating for l-2 h at 5O”C, 1 pl of elution mixture 
was used to generate single strand DNA after PCR amplifica- 
tion using unequal molar amounts of primers [lo]: the mixtures 
containing 0.1 pmol of 5 ’ primer and 50 pmol of 3 ’ primer (or 
the reciprocal primer ratio) were subjected to 15-20 cycles of 
polymerisation-denaturation. The nucleotide sequences were 
determined using modified T7 DNA polymerase (sequenase 
USB) according to the manufacturer’s recommendations. 
2.4. Analysis of PCR amplified products 
5- 10 ~1 of mixture from cDNA amplification were run on 
2% agarose gel and transferred to Biodyne B nylon membranes 
(Pall Industry, NY) in 0.2 N NaOH. Membranes were hybridiz- 
ed with l-5 x lo6 cpm of 5’ 32P-labelled oligonucleotide and 
washed with 3 M tetramethylammonium chloride following the 
procedure described in [ 111. 
3. RESULTS AND DISCUSSION 
We have analyzed transcripts from the ,&-globin 
gene in reticulocytes of a subject affected by ,&- 
thalassemia. This ,&thalassemia was related to a 
homozygous T-C transition in the CT 
dinucleotide of the first splice junction of the ,f3- 
globin gene. 
cDNA was prepared from RNA extracted from 
circulating reticulocytes. A primer was used to 
generate DNA fragments complementary to the 5 ’ 
end of the ,&globin mRNA. Double-stranded 
cDNA was further synthesized and PCR amplified 
using this primer and another located in the 5 ’ 
non-coding end of the mRNA. In the normally 
spliced mRNA this results in the amplification of 
a 216 base-pairs long DNA fragment. This region 
is interrupted in the &globin gene by a non-coding 
sequence (IVS 1) 130 base-pairs long. Amplifica- 
tion products were analyzed by gel electrophoresis 
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(fig. 1A). Five main bands were detected exhibiting 
an apparent migration of about 72-180-215-230 
and 240 base pairs. 
In order to identify products that contain ,0- 
globin mRNA sequences, amplified cDNA were 
transferred onto a nylon membrane and hybridized 
to an oligonucleotide of complementary sequences 
of the second exon of the @globin gene [8] 
(fig.lB). 
Under stringent washing conditions, only DNA 
of an apparent length of 180-215-230 and 240 
base pairs remained hybridized to the probe. We 
verified that the use of an oligonucleotide differing 
only by a single central mismatch does not elicit 
any autoradiographic signal (not illustrated). The 
215 base pairs fragment, whose size corresponded 
to that expected from a normal splicing event, was 
indeed observed in the @globin cDNA of a normal 
subject (fig.1, lane 1). The other fragments can be 
related to the expressions of cryptic splicing sites. 
In order to locate the splicing sites, amplified ,&- 
globin cDNA were separated in acrylamide gel; the 
four ,&globin-related DNA fragments were ex- 
tracted from the gel and further PCR amplified us- 
ing an unequal molar ratio of primer to allow 
accurate nucleotide sequence determination. Two 
cryptic splicing sites were identified at position 
-38 upstream of the normal splicing site and posi- 
tion +13 downstream (fig.2). These two sites and 
another - 16 upstream were previously located us- 
ing different approaches [12,131. 
Using the primers described above, we failed to 
obtain readable patterns concerning the nucleotide 
sequence of the cDNA which migrated at an ap- 
parent size of 240 base pairs. This may indicate 
that this cDNA consists of a mosaic of different 
cDNA [6]. To verify this hypothesis we amplified 
this cDNA using the 3’ primer (palm 4) and 
another primer located only 30 bases upstream of 
the normal 5’ splicing junction. Nucleotide se- 
quences of the product thus obtained are il- 
lustrated in fig.3. The main component of the 
cDNA was a product that can be related to the use 
of the cryptic site at position + 13 (see fig.2B). The 
presence of other components in the studied DNA 
is derived from the appearance of minor bands in 
the background of the autoradiograms. This result 
indicates that this 240 base pairs DNA fragment is 
indeed a mosaic of the 230 base-long cDNA, and 
other &globin or non-,f3-globin cDNA. The 
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Fig.1. Analysis by agarose gel and Southern blot of the ,i?- 
globin-related cDNA. Transcripts from the thalassemia 
affected patient (2) and those from a normal subject (I) are 
compared. Molecular weight markers (MW) are fragments of 
Hue111 digested x174 RF DNA. Transcripts were resolved by 
agarose gel electrophoresis (A), transferred onto a nylon 
membrane and hybridized to a,%globin-specific oligonucleotide 
probe(B). The apparent size of the fragments hybridizing to the 
probe is indicated. The autoradiogr~ was voluntarily 
overexposed in order to visualize bands of very low intensity. 
polymorphic structure of such an entity could ac- 
count for its electrophoretic mobility. 
The patient studied in the present report was af- 
fected by a ,&halassemia that can be related to the 
almost entire absence of normally spliced @globin 
mRNA. The results illustrated in fig. 1 indicate that 
the method used allows the detection of the normal 
@globin mRNA while mRNA resulting from splic- 
ing at position + 16 [12,13] was not detected. Stu- 
dying the effect of 3 mutations: (IVS 1-l G-A, 
IVS 1-5 G-C and IVS l-6 T-C) in transform- 
ed cells, Treisman et al. [12] observed in each case 
T G C A 
B 
Exon 1 IVS Exoll2 
-3% N +13 
Fig.2. Localization of the splice sites producing@-globin related 
mRNAs. cDNA was prepared from reticulocyte mRNA of the 
thaiassemic patient. The nucleotide sequence of the @-globin- 
related mRNA was determined. (A) A sequence flanking the 
splice junction IV.8 I+ 13 (indicated by the arrow) is illustrated. 
The template was the non-coding strand of the DNA. (B) 
Diagram showing the position of splicing sites deduced from the 
determination of the nucleotide sequences of the fl-globin- 
related cDNAs. Three splicing sites were localized: IVS l-38, 
the normal splicing site (N) and IVS 1+ 13. Asterisk denotes the 
T--C transition at the 5’ signal of splicing. 
the 3 cryptic splicing sites. The analysis of in vitro 
transcripts 1131 from genes carrying two other 
mutations (IVS l-2 T-G and IVS l-l G-C) 
leads to a similar conclusion. Although slight dif- 
ferences were observed in the degree of activation 
of cryptic sites, depending on the mutation, the 
165 
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Fig.3. Determination of the composition of the@globin-related 
cDNA migrating at an apparent size of 240 base pairs. The 
sequence obtained from reading bands of greater intensity is 
indicated and is identical to that of fig.;?. The template was the 
coding strand of the DNA. The simultaneous presence of less 
intense bands suggests that the analysed DNA is a mosaic of one 
main product and other less represented products. 
results indicated that the same cryptic splicing sites 
were involved; cryptic site - 16 being the most effi- 
cient. If we agree with the hypothesis that sequence 
complementarity with Ul snRNA [14] is responsi- 
ble for the abnormal splicing, the location of alter- 
native sites should be independent of the mutation 
at the splice junction. Using the in vivo approach 
described here on a patient who carried a mutation 
at the IVS 1 splice junction, we observed that the 
-38 and i-13 cryptic sites were indeed used. We 
have not observed mature mRNA deriving from 
effective splicing at position -16. Instability of 
these other potential transcripts could explain 
these observations. However, this is not consistent 
with the sensitivity of the detection method [ 151. 
Better explanations would either be that splicing 
does not occur at every potential cryptic site or that 
only the products issued from specific cryptic sites 
are adequately transferred to the cytoplasm of the 
cells. Further studies would be needed to decipher 
the actual mechanism which leads to the selection 
of this abnormal mRNA. 
In any case, our results do not entirely corres- 
pond to those obtained in similar situations using 
transformed cells or in vitro analysis. 
The approach developed here is of potential in- 
terest in the rapid analysis of the products of many 
genomic defects. Although homozygosity 
facilitates accurate analysis of the effect of 
recessive abnormalities, this approach could be ex- 
tended to heterozygous or double heterozygous if 
both genetic defects are sufficiently far from each 
other to be analyzed separately. 
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